These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 15240431)

  • 1. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
    Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
    Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
    Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
    Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
    Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
    Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
    Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
    J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
    Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
    Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1.
    Mascalchi M; Tosetti M; Plasmati R; Bianchi MC; Tessa C; Salvi F; Frontali M; Valzania F; Bartolozzi C; Tassinari CA
    Ann Neurol; 1998 Feb; 43(2):244-52. PubMed ID: 9485066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
    Villanueva V; Alvarez-Linera J; Gómez-Garre P; Gutiérrez J; Serratosa JM
    Epilepsia; 2006 Apr; 47(4):788-92. PubMed ID: 16650146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum.
    Mascalchi M; Brugnoli R; Guerrini L; Belli G; Nistri M; Politi LS; Gavazzi C; Lolli F; Argenti G; Villari N
    J Magn Reson Imaging; 2002 Nov; 16(5):532-7. PubMed ID: 12412029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia.
    Mascalchi M; Cosottini M; Lolli F; Salvi F; Tessa C; Macucci M; Tosetti M; Plasmati R; Ferlini A; Tassinari CA; Villari N
    Radiology; 2002 May; 223(2):371-8. PubMed ID: 11997539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias.
    Guerrini L; Belli G; Mazzoni L; Foresti S; Ginestroni A; Della Nave R; Diciotti S; Mascalchi M
    J Magn Reson Imaging; 2009 Jul; 30(1):11-7. PubMed ID: 19557841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MR of the brain: methodology and clinical application.
    Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
    Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes.
    Prakash N; Hageman N; Hua X; Toga AW; Perlman SL; Salamon N
    Neuroimage; 2009 Aug; 47 Suppl 2():T72-81. PubMed ID: 19446636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
    Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
    Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pontine and cerebellar atrophy correlate with clinical disability in SCA2.
    Ying SH; Choi SI; Perlman SL; Baloh RW; Zee DS; Toga AW
    Neurology; 2006 Feb; 66(3):424-6. PubMed ID: 16476946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
    Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
    Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
    Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
    Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between proton magnetic resonance spectroscopy measurements and CAG repeat number in patients with spinocerebellar ataxias 2, 3, or 6.
    Wang PS; Chen HC; Wu HM; Lirng JF; Wu YT; Soong BW
    PLoS One; 2012; 7(10):e47479. PubMed ID: 23094053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration.
    Tedeschi G; Bertolino A; Massaquoi SG; Campbell G; Patronas NJ; Bonavita S; Barnett AS; Alger JR; Hallett M
    Ann Neurol; 1996 Jan; 39(1):71-8. PubMed ID: 8572670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.